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Mbewu ducks AIDS deaths
To the Editor: As public health specialists we read with dismay
a recent Medical Research Council (MRC) media release,1 later
reprinted in the press,2 written by Mbewu in both his personal
and official capacities as the interim president of the MRC.
Entitled ‘Deaths, causes of deaths and rumours of deaths’, the
piece appeared to be an intervention in a debate on whether
the burden of AIDS deaths can be inferred from explicit death
certification alone. It asserts, inter alia, that ‘cause of death
information from death certificates are the most reliable and
validated measures of mortality and changes in mortality’.
We conclude from the timing of the release that it was
produced in anticipation of a report on death certifications by
Stats SA requested by President Mbeki and that it was directed,
inter alia, at a publication by MRC and University of Cape
Town researchers of an empirical analysis of death
certifications designed to arrive at a complete picture of HIV-
related deaths.3
There are many reasons why HIV might not appear on the
death certificate of a person who has died an HIV-related
death, and a substantial discrepancy between the raw data and
the empirical estimate was expected.  There is nothing sinister
about this discrepancy, nor does there appear to be any conflict
of opinion between government statisticians and epidemio-
logists about the need to apply empirical analysis and
demographic modelling to death certificate data to estimate the
burden of AIDS deaths needed for public policy making.4
Unfortunately, instead of clarifying matters for the public,
the media release expends considerable space in defending
death certification as a ‘gold standard’ for public policy making
and suggests that it is mainly in developing countries with
inadequate death registration coverage that epidemiological
analysis is needed.  In putting forward this argument the
release appears to confuse certification of the fact of death with
certification of the medical cause of death, and fails to make
the distinction between immediate and underlying cause of
death.
Ignorance as to the deceased’s HIV infection status and
various pressures to maintain confidentiality where such status
is known are obvious reasons why a medical practitioner may
not certify HIV infection as the underlying cause of death on
the death certificate. Further, contrary to what is asserted in the
press release, medical practitioners are generally poor at
accurate cause-of-death certification to the degree required for
epidemiological analysis and public policy.5 They have little if
any training in such certification. There is a large international
literature showing this in relation to many conditions, let alone
one attended by as high a degree of fear and stigma as AIDS.
To take a local example, a recent study of death certification at
a provincial teaching hospital found that 78.9% of 304 deaths in
1 year were certified as due to ‘cardiorespiratory failure’, an
uninformative category.6 
It is to the credit of the government to have improved death
registration coverage and to be able to provide the data to
which scientific reasoning and techniques can be applied to get
the best estimate of the toll of AIDS and other causes of death.
To try to diminish in the eyes of the public the essential role of
science in this combined effort is a strange and unfortunate role
for the interim president of a science council to play.  The effect
is to undermine the value of scientific reasoning and an
evidence-based approach to public policy that we would
expect to be championed by the MRC.
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Criteria for chronic dialysis
To the Editor: Chronic kidney disease and kidney failure are
serious health problems in any society. The fact that these
disorders are highly prevalent in our developing country and
substantially increase the risk of hypertension and death from
cardiovascular disease has made chronic kidney disease an
important public health problem for all South Africans.
Furthermore, it is recognised that economic disparities and
competing public health problems in South Africa have made it
far more difficult to formulate a series of standards that could
be applicable to all individuals with chronic kidney failure.
With the shortage of transplantable organs, dialysis is often the
only form of adequate renal replacement therapy. When these
patients develop end-stage kidney failure the aim of selection
198
340257-198-200-SMJ0405  3/4/05  10:35  Page 198
BRIEWE
200
April 2005, Vol. 95, No. 4  SAMJ
for dialysis (haemodialysis or peritoneal dialysis) should be to
use scarce resources to provide maximum benefit while
affording such patients a good quality of life.  Race, colour,
creed, political affiliation and chronic disease (such as diabetes)
should not influence selection and age should not be a criterion
either.1 Moreover, patients suffering from hepatitis B and C or
HIV should not be excluded from dialysis therapy especially
when receiving concomitant antiretroviral therapy, as their
outcomes are similar to those of non-infected patients.2
To this end selection should be the responsibility of the
treating nephrologist together with the nephrology team (social
workers, psychologists, nursing staff) who are best qualified to
judge prognosis and benefit from therapy. Patients with a poor
overall prognosis, as assessed by the nephrologist and team,
should receive optimal conservative therapy. 
Response to therapy, patient outcomes and cost-effectiveness
of treatment should be monitored, both by the treating dialysis
units and by a peer-reviewed national nephrology forum or
registry. Such close monitoring will not only improve the
patient’s lot but will also ensure adequate and economic
dialysis in the private and public sectors.   
Gone are the days when the state should be allowed to make
draconian decisions on patient management, and I believe it is
essential that all parties involved in dialysis therapy be
consulted before any national criteria for dialysis are adopted.
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Caesarean section — claims and
concerns
To the Editor: The article on caesarean section (CS) in a recent
issue of the Journal1 raises many interesting points.
Unfortunately your senior news journalist does not reveal his
sources so we have no way of verifying the claim that in
privately funded health facilities 65% of women deliver their
babies by CS compared with 10 - 20% in public health facilities,
or that 65% is ‘almost double the percentages in the UK and
USA’. 
Nevertheless, assuming that these claims are correct and
while costs of medical care are always a concern, surely our
primary interest must be health outcomes? In this regard it
would be interesting to see comment on the respective
morbidity and mortality rates for babies born by CS compared
with those delivered pelvically. To eliminate compounding
variables, that study would presumably best be done in our
public institutions. Anecdotally, the virtual absence in our
practice of hypoxic ischaemic encephalopathy following
elective CS suggests that CS may be of protective benefit to the
child.
Of equal concern are the effects on women of ill-advised
vaginal delivery. While the focus of these articles is usually on
rates of CS and the direct cost of that mode of delivery, I have
not seen commentators reflect on the substantial longer-term
cost of repairs to the damaged pelvic floor and perinea in
women who have delivered their babies vaginally. The
psychological and physical morbidity related to urinary stress
incontinence, cystoceles, rectoceles, prolapse, anal incontinence,
dyspareunia, etc. is substantial. Any sensible economic
appraisal of costs of caesarean versus pelvic ‘normal delivery’
ought to compute the costs of repair of the pelvic floor, vagina
and perineum later in women’s lives.
I am a paediatrician in private practice with part-time
public hospital appointments. I am in favour of the mode of
delivery that in each case brings the best health outcome to
mother and baby. I believe that patients enjoy certain rights
under our constitution, one of which is to make informed
decisions about procedures and interventions that may affect
their health and the health of their babies. I am also, therefore,
pro choice.
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